These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 11710769)

  • 1. Evolution of Tc-99m in diagnostic radiopharmaceuticals.
    Banerjee S; Pillai MR; Ramamoorthy N
    Semin Nucl Med; 2001 Oct; 31(4):260-77. PubMed ID: 11710769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newer methods of labeling diagnostic agents with Tc-99m.
    Mease RC; Lambert C
    Semin Nucl Med; 2001 Oct; 31(4):278-85. PubMed ID: 11710770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of electrospray mass spectrometry for the characterization, design, and development of nitrido technetium and rhenium heterocomplexes as potential radiopharmaceuticals.
    Tisato F; Bolzati C; Porchia M; Refosco F
    Mass Spectrom Rev; 2004; 23(5):309-32. PubMed ID: 15264232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chemistry of 99mTc-labeled radiopharmaceuticals.
    Dewanjee MK
    Semin Nucl Med; 1990 Jan; 20(1):5-27. PubMed ID: 2404341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New and versatile ternary ligand system for technetium radiopharmaceuticals: water soluble phosphines and tricine as coligands in labeling a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTc.
    Edwards DS; Liu S; Barrett JA; Harris AR; Looby RJ; Ziegler MC; Heminway SJ; Carroll TR
    Bioconjug Chem; 1997; 8(2):146-54. PubMed ID: 9095354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Technetium-99m radiopharmaceuticals for in vivo diagnostics].
    Dokić DD
    Med Pregl; 2005; 58(3-4):180-4. PubMed ID: 16526218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Efficacy of Sodium [99mTc] Pertechnetate from Low Specific Activity 99Mo/99mTc Autosolex Generator in Hospital Radiopharmacy Centre.
    Mitra A; Chattopadhyay S; Chandak A; Lad S; Barua L; De A; Kumar U; Chinagandham R; Upadhye T; Koundal K; Banerjee S; Rajan R
    Nucl Med Rev Cent East Eur; 2020; 23(1):1-14. PubMed ID: 32779168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 99mTc Injected Activity with Prescribed Activity in Four Types of Nuclear Medicine Exams.
    Khan MI; Farwa U; Iqbal T; Ali S; Nazir A; Ijaz M
    Curr Radiopharm; 2020; 13(1):80-85. PubMed ID: 31258094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in 99mTc radiopharmaceuticals.
    Arano Y
    Ann Nucl Med; 2002 Apr; 16(2):79-93. PubMed ID: 12043913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technetium-99m-EC and other potential new agents in renal nuclear medicine.
    Moran JK
    Semin Nucl Med; 1999 Apr; 29(2):91-101. PubMed ID: 10321823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetraamine-derived bifunctional chelators for technetium-99m labelling: synthesis, bioconjugation and evaluation as targeted SPECT imaging probes for GRP-receptor-positive tumours.
    Abiraj K; Mansi R; Tamma ML; Forrer F; Cescato R; Reubi JC; Akyel KG; Maecke HR
    Chemistry; 2010 Feb; 16(7):2115-24. PubMed ID: 20066690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, characterization, and labeling with 99mTc/188Re of peptide conjugates containing a dithia-bisphosphine chelating agent.
    Gali H; Hoffman TJ; Sieckman GL; Owen NK; Katti KV; Volkert WA
    Bioconjug Chem; 2001; 12(3):354-63. PubMed ID: 11353532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of clinical-scale 99Mo/99mTc column generator using neutron activated low specific activity 99Mo and nanocrystalline γ-Al2O3 as column matrix.
    Chakravarty R; Ram R; Dash A; Pillai MR
    Nucl Med Biol; 2012 Oct; 39(7):916-22. PubMed ID: 22632898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transition metal chemistry of main group hydrazides, Part 14: Evaluation of new Tc-99m chelates of thiol functionalized phosphorus hydrazides.
    Singh PR; Lusiak P; Volkert WA; Ketring AR; Holmes RA; Katti KV
    Nucl Med Biol; 1995 Oct; 22(7):849-57. PubMed ID: 8547882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (99m)Tc and (111)In-labeling of small biomolecules: bifunctional chelators and related coordination chemistry.
    Chakraborty S; Liu S
    Curr Top Med Chem; 2010; 10(11):1113-34. PubMed ID: 20388113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Labeling and biodistribution studies of Tc-99m radiopharmaceuticals with (o-hydroxyphenyl)diphenylphosphine.
    Bolzati C; Uccelli L; Refosco F; Tisato F; Duatti A; Giganti M; Piffanelli A
    Nucl Med Biol; 1998 Jan; 25(1):71-6. PubMed ID: 9466365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of glutamate-sensitive radiopharmaceuticals: Technetium-99m-glutamic acid and technetium-99m-diethylenetriaminepentaacetic acid-bis(glutamate) conjugate for tumor imaging.
    Kakkar D; Tiwari AK; Chuttani K; Kaul A; Singh H; Mishra AK
    Cancer Biother Radiopharm; 2010 Dec; 25(6):645-55. PubMed ID: 21204758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highlights of the annual meeting of the European Association of Nuclear Medicine, Düsseldorf 1994.
    Knapp WH
    Eur J Nucl Med; 1995 Jan; 22(1):69-80. PubMed ID: 7698158
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis and evaluation of a novel
    Song X; Wang Y; Zhang J; Jin Z; Zhang W; Zhang Y
    Chem Biol Drug Des; 2018 Feb; 91(2):545-551. PubMed ID: 28994250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.